On June 3, 2022 Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, reported that John Butler, Chief Executive Officer, will present at the Jefferies Healthcare Conference on Thursday, June 9, 2022 at 10:30 a.m. ET (Press release, Akebia, JUN 3, 2022, View Source [SID1234615528]). The Jefferies Healthcare Conference will take place June 8-10, 2022, in New York.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
A live webcast of the presentation can be accessed through the Investors section of Akebia’s website at View Source A replay of the webcast will also be available for approximately 90 days following the conference through the Investors section of Akebia’s website at View Source